176 related articles for article (PubMed ID: 37353617)
1. Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263.
Wang L; Li G; Zhou Z; Ge C; Chen Q; Liu Y; Zhang N; Zhang K; Niu M; Li W; Zhong X; Wu S; Zhang J; Liu Y
Oncogene; 2023 Jul; 42(30):2329-2346. PubMed ID: 37353617
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of OGT by Caveolin-1 promotes hepatocellular carcinoma cell migration and invasion.
Wang L; Feng Y; Zhang C; Chen X; Huang H; Li W; Zhang J; Liu Y
Cell Biol Int; 2021 Nov; 45(11):2251-2263. PubMed ID: 34288245
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity.
Huang H; Wu Q; Guo X; Huang T; Xie X; Wang L; Liu Y; Shi L; Li W; Zhang J; Liu Y
J Cell Physiol; 2021 Nov; 236(11):7491-7503. PubMed ID: 33843053
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation of RAB10 promotes hepatocellular carcinoma progression.
Lv Z; Ma G; Zhong Z; Xie X; Li B; Long D
Carcinogenesis; 2023 Dec; 44(10-11):785-794. PubMed ID: 37218374
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.
Xu W; Zhang X; Wu JL; Fu L; Liu K; Liu D; Chen GG; Lai PB; Wong N; Yu J
J Hepatol; 2017 Aug; 67(2):310-320. PubMed ID: 28347804
[TBL] [Abstract][Full Text] [Related]
8. Identification of a diketopiperazine-based O-GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition.
Shan X; Jiang R; Gou D; Xiang J; Zhou P; Xia J; Wang K; Huang A; Tang N; Huang L
FEBS J; 2023 Sep; 290(18):4543-4561. PubMed ID: 37247228
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
[TBL] [Abstract][Full Text] [Related]
10. Histone methyltransferase Dot1L recruits O-GlcNAc transferase to target chromatin sites to regulate histone O-GlcNAcylation.
Xu B; Zhang C; Jiang A; Zhang X; Liang F; Wang X; Li D; Liu C; Liu X; Xia J; Li Y; Wang Y; Yang Z; Chen J; Zhou Y; Chen L; Sun H
J Biol Chem; 2022 Jul; 298(7):102115. PubMed ID: 35690146
[TBL] [Abstract][Full Text] [Related]
11. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
[TBL] [Abstract][Full Text] [Related]
12. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T
Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694
[TBL] [Abstract][Full Text] [Related]
13. Undetectable histone O-GlcNAcylation in mammalian cells.
Gagnon J; Daou S; Zamorano N; Iannantuono NV; Hammond-Martel I; Mashtalir N; Bonneil E; Wurtele H; Thibault P; Affar el B
Epigenetics; 2015; 10(8):677-91. PubMed ID: 26075789
[TBL] [Abstract][Full Text] [Related]
14. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization.
You Z; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X
J Cell Mol Med; 2021 Oct; 25(19):9168-9182. PubMed ID: 34510715
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.
Zhou P; Chang WY; Gong DA; Huang LY; Liu R; Liu Y; Xia J; Wang K; Tang N; Huang AL
Oncogene; 2023 Mar; 42(10):725-736. PubMed ID: 36604567
[TBL] [Abstract][Full Text] [Related]
16. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
Lai CY; Liu H; Tin KX; Huang Y; Yeh KH; Peng HW; Chen HD; He JY; Chiang YJ; Liu CS; Weng SY; Tao MH; Yen JJ; Yang-Yen HF
Oncogene; 2019 Jan; 38(3):317-331. PubMed ID: 30097606
[TBL] [Abstract][Full Text] [Related]
17. OGT functions as a catalytic chaperone under heat stress response: a unique defense role of OGT in hyperthermia.
Sohn KC; Lee KY; Park JE; Do SI
Biochem Biophys Res Commun; 2004 Sep; 322(3):1045-51. PubMed ID: 15336570
[TBL] [Abstract][Full Text] [Related]
18. RANBP2 Activates
Liu X; Chen X; Xiao M; Zhu Y; Gong R; Liu J; Zeng Q; Xu C; Chen X; Wang F; Cao K
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298689
[No Abstract] [Full Text] [Related]
19. E2F1 Transcription Factor Regulates O-linked N-acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Expression.
Muthusamy S; Hong KU; Dassanayaka S; Hamid T; Jones SP
J Biol Chem; 2015 Dec; 290(52):31013-24. PubMed ID: 26527687
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N
Yang Y; Yan Y; Yin J; Tang N; Wang K; Huang L; Hu J; Feng Z; Gao Q; Huang A
Signal Transduct Target Ther; 2023 Feb; 8(1):63. PubMed ID: 36765030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
